Klarithran Mr 500 500 mg Tablet.
PDF Leaflet Revision Date: 23 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderately severe infections.
Dosage (summary)
500 mg once daily with food; may increase to 2 x 500 mg for severe infections.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established; excreted in breast milk.
Key Drug Interactions
- Astemizole
- Warfarin
- Digoxin
- Simvastatin
- Rifabutin
- Theophylline
Contraindications
- Hypersensitivity to macrolides
- Concomitant use with certain drugs
- Porphyria
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Headache
- QT prolongation
Counselling Points
- Take with food
- Monitor for signs of hepatic dysfunction
- Report any unusual symptoms
Serious warnings
- Hepatic dysfunction
- Rhabdomyolysis risk
- Severe renal impairment
Important Disclaimer
The Klarithran Mr 500 500 mg Tablet. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
